303 related articles for article (PubMed ID: 15385485)
1. Merozoite surface protein 4/5 provides protection against lethal challenge with a heterologous malaria parasite strain.
Goschnick MW; Black CG; Kedzierski L; Holder AA; Coppel RL
Infect Immun; 2004 Oct; 72(10):5840-9. PubMed ID: 15385485
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the protective efficacy of yeast-derived and Escherichia coli-derived recombinant merozoite surface protein 4/5 against lethal challenge by Plasmodium yoelii.
Kedzierski L; Black CG; Stowers AW; Goschnick MW; Kaslow DC; Coppel RL
Vaccine; 2001 Sep; 19(32):4661-8. PubMed ID: 11535314
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the merozoite surface protein 4/5 gene of Plasmodium berghei and Plasmodium yoelii.
Kedzierski L; Black CG; Coppel RL
Mol Biochem Parasitol; 2000 Jan; 105(1):137-47. PubMed ID: 10613706
[TBL] [Abstract][Full Text] [Related]
4. Immunization with a combination of merozoite surface proteins 4/5 and 1 enhances protection against lethal challenge with Plasmodium yoelii.
Kedzierski L; Black CG; Goschnick MW; Stowers AW; Coppel RL
Infect Immun; 2002 Dec; 70(12):6606-13. PubMed ID: 12438332
[TBL] [Abstract][Full Text] [Related]
5. Rhop-3 protein conservation among Plasmodium species and induced protection against lethal P. yoelii and P. berghei challenge.
Wang T; Fujioka H; Drazba JA; Sam-Yellowe TY
Parasitol Res; 2006 Aug; 99(3):238-52. PubMed ID: 16541261
[TBL] [Abstract][Full Text] [Related]
6. The protective efficacy of MSP4/5 against lethal Plasmodium chabaudi adami challenge is dependent on the type of DNA vaccine vector and vaccination protocol.
Rainczuk A; Smooker PM; Kedzierski L; Black CG; Coppel RL; Spithill TW
Vaccine; 2003 Jun; 21(21-22):3030-42. PubMed ID: 12798647
[TBL] [Abstract][Full Text] [Related]
7. Immunization with a recombinant C-terminal fragment of Plasmodium yoelii merozoite surface protein 1 protects mice against homologous but not heterologous P. yoelii sporozoite challenge.
Rénia L; Ling IT; Marussig M; Miltgen F; Holder AA; Mazier D
Infect Immun; 1997 Nov; 65(11):4419-23. PubMed ID: 9353014
[TBL] [Abstract][Full Text] [Related]
8. Plasmodium: immunization with carboxyl-terminal regions of MSP-1 protects against homologous but not heterologous blood-stage parasite challenge.
Rotman HL; Daly TM; Long CA
Exp Parasitol; 1999 Jan; 91(1):78-85. PubMed ID: 9920045
[TBL] [Abstract][Full Text] [Related]
9. Oral immunization with a combination of Plasmodium yoelii merozoite surface proteins 1 and 4/5 enhances protection against lethal malaria challenge.
Wang L; Goschnick MW; Coppel RL
Infect Immun; 2004 Oct; 72(10):6172-5. PubMed ID: 15385527
[TBL] [Abstract][Full Text] [Related]
10. A new malaria antigen produces partial protection against Plasmodium yoelii challenge.
Zhang Y; Qi Y; Li J; Liu S; Hong L; Lin T; Long C; Su XZ
Parasitol Res; 2012 Apr; 110(4):1337-45. PubMed ID: 21915626
[TBL] [Abstract][Full Text] [Related]
11. Immunization with parasite-derived apical membrane antigen 1 or passive immunization with a specific monoclonal antibody protects BALB/c mice against lethal Plasmodium yoelii yoelii YM blood-stage infection.
Narum DL; Ogun SA; Thomas AW; Holder AA
Infect Immun; 2000 May; 68(5):2899-906. PubMed ID: 10768987
[TBL] [Abstract][Full Text] [Related]
12. Passive immunization with a multicomponent vaccine against conserved domains of apical membrane antigen 1 and 235-kilodalton rhoptry proteins protects mice against Plasmodium yoelii blood-stage challenge infection.
Narum DL; Ogun SA; Batchelor AH; Holder AA
Infect Immun; 2006 Oct; 74(10):5529-36. PubMed ID: 16988228
[TBL] [Abstract][Full Text] [Related]
13. Immunization with the MAEBL M2 Domain Protects against Lethal Plasmodium yoelii Infection.
Leite JA; Bargieri DY; Carvalho BO; Albrecht L; Lopes SC; Kayano AC; Farias AS; Chia WN; Claser C; Malleret B; Russell B; Castiñeiras C; Santos LM; Brocchi M; Wunderlich G; Soares IS; Rodrigues MM; Rénia L; Costa FT
Infect Immun; 2015 Oct; 83(10):3781-92. PubMed ID: 26169268
[TBL] [Abstract][Full Text] [Related]
14. Plasmodium berghei circumvents immune responses induced by merozoite surface protein 1- and apical membrane antigen 1-based vaccines.
Yoshida S; Nagumo H; Yokomine T; Araki H; Suzuki A; Matsuoka H
PLoS One; 2010 Oct; 5(10):e13727. PubMed ID: 21060850
[TBL] [Abstract][Full Text] [Related]
15. Protective immunization with a novel membrane protein of Plasmodium yoelii-infected erythrocytes.
Burns JM; Adeeku EK; Dunn PD
Infect Immun; 1999 Feb; 67(2):675-80. PubMed ID: 9916076
[TBL] [Abstract][Full Text] [Related]
16. A bicistronic DNA vaccine containing apical membrane antigen 1 and merozoite surface protein 4/5 can prime humoral and cellular immune responses and partially protect mice against virulent Plasmodium chabaudi adami DS malaria.
Rainczuk A; Scorza T; Spithill TW; Smooker PM
Infect Immun; 2004 Oct; 72(10):5565-73. PubMed ID: 15385453
[TBL] [Abstract][Full Text] [Related]
17. Immunization with recombinant Plasmodium yoelii merozoite surface protein 4/5 protects mice against lethal challenge.
Kedzierski L; Black CG; Coppel RL
Infect Immun; 2000 Oct; 68(10):6034-7. PubMed ID: 10992516
[TBL] [Abstract][Full Text] [Related]
18. Antigenic and sequence diversity at the C-terminus of the merozoite surface protein-1 from rodent malaria isolates, and the binding of protective monoclonal antibodies.
Benjamin PA; Ling IT; Clottey G; Valero LM; Ogun SA; Fleck SL; Walliker D; Morgan WD; Birdsall B; Feeney J; Holder AA
Mol Biochem Parasitol; 1999 Nov; 104(2):147-56. PubMed ID: 10593171
[TBL] [Abstract][Full Text] [Related]
19. Immunization with a functional protein complex required for erythrocyte invasion protects against lethal malaria.
Srinivasan P; Ekanem E; Diouf A; Tonkin ML; Miura K; Boulanger MJ; Long CA; Narum DL; Miller LH
Proc Natl Acad Sci U S A; 2014 Jul; 111(28):10311-6. PubMed ID: 24958881
[TBL] [Abstract][Full Text] [Related]
20. The Plasmodium vivax homologues of merozoite surface proteins 4 and 5 from Plasmodium falciparum are expressed at different locations in the merozoite.
Black CG; Barnwell JW; Huber CS; Galinski MR; Coppel RL
Mol Biochem Parasitol; 2002 Apr; 120(2):215-24. PubMed ID: 11897127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
